Trendingnow
Tech

By Nick LichtenbergAugust 30, 2026

Trump backlash adds new risks to the stocks the government owns
By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026


By Carolina Rossini and The ConversationAugust 28, 2026

By Jeffrey C. Dixon and The ConversationAugust 29, 2026

By Kamal AhmedAugust 27, 2026

By Catherina GioinoAugust 28, 2026
Latest stories from Fortune
More TechPage 49 of 100

By Nick LichtenbergJune 1, 2026

By Catherina GioinoJune 1, 2026

By Allie GarfinkleJune 1, 2026

By The Associated PressJune 1, 2026

By Marco Quiroz-GutierrezJune 1, 2026

By Nick LichtenbergJune 1, 2026

By Bloomberg and Seth FiegermanJune 1, 2026

By Catherina GioinoJune 1, 2026

By Jacqueline MunisJune 1, 2026

By Emma BurleighJune 1, 2026

By The Associated Press and Matt O'BrienJune 1, 2026

By The Associated Press, Chan Ho-Him and TAIJING WUJune 1, 2026

By The Associated Press and Eileen NgJune 1, 2026

By Jack KubinecJune 1, 2026

By Kristin StollerJune 1, 2026

By Nick LichtenbergJune 1, 2026

By Ben WeissJune 1, 2026

By Andrew NuscaJune 1, 2026

By Nick LichtenbergJune 1, 2026

By Jason MaMay 31, 2026

By Lindsey Bahr and The Associated PressMay 31, 2026

By Catherina GioinoMay 31, 2026

By Jake AngeloMay 31, 2026

By Marco Quiroz-GutierrezMay 31, 2026

By Lauran Neergaard and The Associated PressMay 31, 2026

By Konstantin Toropin and The Associated PressMay 31, 2026

By Bill NyeMay 31, 2026
Most Popular



















